Why is Moldova becoming a hidden gem for clinical research and pharmaceutical logistics?

Why is Moldova becoming a hidden gem for clinical research and pharmaceutical logistics?

From doubling the number of clinical trials to expanding its healthcare infrastructure, Moldova is quietly becoming one of the most promising destinations for pharma innovation in the region.

With over 290 clinical studies in 2024, a streamlined regulatory process, and growing interest from international pharma companies, Moldova offers real opportunities—but also challenges that require local knowledge and strong logistical support.

At COREX, we’ve been on the ground supporting this transformation—from import/export compliance to clinical trial supply and stakeholder coordination.

Discover what’s driving Moldova’s momentum and how global partners can navigate this evolving landscape

Back to the list